Dow Down 0.13% Nasdaq Up 0.14%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
2.26 Down 0.03(1.31%) Jul 29, 4:00PM EDT
Prev Close:2.29
Open:2.30
Bid:2.00 x 1000
Ask:2.69 x 2000
1y Target Est:10.14
Beta:0.721285
Next Earnings Date: 3-Aug-16CNAT Earnings announcement
Day's Range:2.21 - 2.32
52wk Range:1.40 - 7.12
Volume:44,241
Avg Vol (3m):120,625
Market Cap:48.02M
P/E (ttm):N/A
EPS (ttm):-1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CNATDown 1.31%48.02M
ICPTUp 3.67%4.26B
GALTUp 4.46%47.53M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.53
Quarterly EPS Est (Jun-16) :-0.38
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback